ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,544Medicare Part D Prescriptions Filled, Including Refills

Rank: 120 out of 1448

$414K Total Retail Price of All Prescriptions

Rank: 192 out of 1448

449 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 6,732 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 716 631 1 2
SIMVASTATIN 456 412 2 3
METOPROLOL SUCCINATE 317 282 3 6
CARVEDILOL 317 270 3 1
WARFARIN SODIUM 311 295 5 8
FUROSEMIDE 307 280 6 7
OMEPRAZOLE 248 226 7 23
COMBIVENT 212 195 8 147
BENAZEPRIL HCL 201 182 9 26
ATORVASTATIN CALCIUM 189 164 10 4
AMIODARONE HCL 178 159 11 22
DIOVAN 162 142 12 15
LISINOPRIL 154 112 13 5
CLOPIDOGREL 138 109 14 10
METFORMIN HCL 127 85 15 25
JANUVIA 126 108 16 64
METOPROLOL TARTRATE 122 91 17 9
LOSARTAN POTASSIUM 121 106 18 11
LEVOTHYROXINE SODIUM 115 115 19 21
ATENOLOL 111 107 20 12
DIGOXIN 109 101 21 13
CRESTOR 108 108 22 17
PLAVIX 103 90 23 14
DIOVAN HCT 99 99 24 29
SPIRIVA 96 84 25 97
TAMSULOSIN HCL 76 69 26 46
ADVAIR DISKUS 74 61 27 74
CLONIDINE HCL 72 54 28 45
ISOSORBIDE MONONITRATE ER 70 56 29 16
PRAVASTATIN SODIUM 68 55 30 20
LIPITOR 66 64 31 30
HYDROCHLOROTHIAZIDE 61 52 32 18
PANTOPRAZOLE SODIUM 55 55 33 42
KLOR-CON 8 53 48 34 70
PRADAXA 52 52 35 27
POTASSIUM CHLORIDE 52 44 35 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.